Zobrazeno 1 - 10
of 298
pro vyhledávání: ''
Autor:
Shoichiro Izawa, Yuichiro Yano, Mitsuhide Naruse, Yoshiro Chiba, Tatsuya Kai, Kouichi Tamura, Norio Wada, Nobuhito Hirawa, Shintaro Okamura, Kenji Oki, Akiyo Tanabe, Takamasa Ichijo, Isao Kurihara, Nobuya Inagaki, Mika Tsuiki, Masanobu Yamada, Takuyuki Katabami, Koichi Yamamoto, Hiroki Kobayashi, Tatsuya Haze
Publikováno v:
Atherosclerosis. 324:84-90
Background and aims We used a dataset from a Japanese nationwide registry of patients with primary aldosteronism, to determine which of the parameters of hyperaldosteronism and blood pressure before or after treatments for primary aldosteronism (i.e.
Autor:
John R Nelson, Suvasini Lakshmanan, Chandana Shekar, Deepak L. Bhatt, Sion K. Roy, April Kinninger, Sajad Hamal, A. Cai, Divya Birudaraju, Christopher Dailing, Matthew J. Budoff, S. Dahal, Ferdinand Flores, Lavanya Cherukuri, A. Onuegbu
Publikováno v:
Atherosclerosis. 305:34-41
Background and aims Dyslipidemia with elevated triglycerides (TGL) and low high-density lipoprotein cholesterol (HDL-C) predicts residual cardiovascular risk, despite goal LDL-C levels and optimal statin therapy. Coronary plaque characterization by C
Autor:
Xia Meng, Hao Li, Jinxi Lin, Yilong Wang, Yongjun Wang, Anxin Wang, Nan Zhang, Guojuan Chen, Liye Dai, Yingting Zuo
Publikováno v:
Atherosclerosis. 297:74-80
Low-density lipoprotein (LDL) and oxidized low-density lipoprotein (oxLDL) levels are thought to be related to recurrent stroke. However, the joint association of circulating LDL and oxLDL levels with the outcomes of acute minor ischemic stroke and t
Autor:
Parveen K. Garg, Steven Shea, Matthew A. Allison, James H. Stein, Laurent Yvan-Chavret, Robyn L. McClelland, Neal W. Jorgensen, Alan R. Tall
Publikováno v:
Atherosclerosis
Background and aims We aimed to assess the relationship of HDL (high-density lipoprotein)-mediated cholesterol mass efflux capacity (CMEC) with risk of incident peripheral artery disease (PAD). Methods CMEC was measured in 1458 Multi-Ethnic Study of
Autor:
Hiroshi Ito, Hirohiko Asonuma, Kunihisa Kohno, Kazuhiko Kotani, Toru Miyoshi, Yasushi Koyama, Satoru Sakuragi, Kazufumi Nakamura, Takashi Miki
Publikováno v:
Atherosclerosis. 283:1-6
Background and aims Oxidized high-density lipoprotein (oxHDL) is characterized by reduced anti-inflammatory properties compared with HDL. However, the role of oxHDL in the pathogenesis of coronary artery calcification (CAC), a marker of subclinical a
Autor:
Anne Pernille Ofstad, Cathrine Brunborg, Kåre I. Birkeland, Odd Erik Johansen, Lars Gullestad, Martin Heier, Mark S. Borja, Knut Endresen, Michael N. Oda
Publikováno v:
Atherosclerosis. 282:183-187
Background and aims Measures of HDL function are emerging tools for assessing cardiovascular disease (CVD) event risk. HDL-apoA-I exchange (HAE) reflects HDL capacity for reverse cholesterol transport. Methods HAE was measured in 93 participants with
Autor:
Isabella Bonilha, Alexandre A.S. Soares, Wilson Nadruz Junior, Luiz Sergio F. Carvalho, Vitor W.M. Virginio, Orlando Petrucci Junior, Jose C. Quinaglia e Silva, Otavio R. Coelho-Filho, Andrei C. Sposito
Publikováno v:
Atherosclerosis. 281:9-16
Coronary reperfusion with HDL from healthy volunteers attenuates ischemia and reperfusion injury in animal models. In myocardial infarction (MI) patients, such an interaction is unclear. Hence, our first objective was to verify if there is interactio
Autor:
Marie-Claude Guertin, Catherine Gebhard, Josep Rodés-Cabau, Jean-Claude Tardif, Reda Ibrahim, Rob S. Beanlands, Eric Rhéaume, Simon Kouz, Shahar Lavi, Gang He, Mariève Cossette, Lawrence M. Title, Jean Grégoire, Philippe L. L’Allier, David Rhainds, J. David Spence
Publikováno v:
Atherosclerosis. 276:131-139
BACKGROUND AND AIMS Lecithin:cholesterol acyltransferase (LCAT), a key enzyme in high-density lipoprotein (HDL) metabolism and reverse cholesterol transport (RCT), has been associated with atheroprotection. However, its relation to plaque characteris
Autor:
Andrea Natali, Beverley Balkau, Frank B. Hu, Bernard Rosner, Sarah A. Aroner, Michaela Kozakova, Jeremy D. Furtado, Ele Ferrannini, Simona Baldi, Frank M. Sacks, Majken K. Jensen, Rain Yamamoto
Publikováno v:
Atherosclerosis. 269:92-99
Background and aims About 6–7% of high density lipoprotein (HDL) has a protein called apolipoprotein (apo) C-III that regulates lipoprotein metabolism and can provoke an inflammatory response. HDL without apoC-III is inversely associated with coron
Autor:
Alberto Cordero, Domingo Orozco-Beltrán, Concepción Carratalá-Munuera, Adriana Lopez-Pineda, Vicente Bertomeu-Martínez, Vicente Bertomeu-González, Vicente Francisco Gil-Guillén, Jose A. Quesada
Publikováno v:
Atherosclerosis
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Background and aims: Many studies have reported the independent association between uric acid and cardiovascular disease, its role as a risk predictor for outcomes in people with acute coronary syndrome remains controversial. This study aims to asses